Search clinical trials for: Levemir

Total 234 results

Rabin Medical Center

Completed

Comparing the Metabolic Control of Once to Twice-daily Insulin Detemir Injections

Type 1 Diabetes Mellitus

Israel
Novo Nordisk A/S

Completed

Observational Study to Evaluate Safety of Levemir® in Type 1 and Type 2 Diabetes

Diabetes Mellitus, Type 2 | Diabetes | Diabetes Mellitus, Type 1

Indonesia
Ohio State University
Novo Nordisk A/S

Completed

Transitioning Open Heart Surgery Patients From Insulin Infusions to Detemir

Diabetes Mellitus

United States
Novo Nordisk A/S

Completed

Evaluation of the Glycaemic Control With Insulin Detemir as an add-on to Current Oral Anti-diabetic Drug Treatment in Subjects With Type 2 Diabetes in Korea

Diabetes Mellitus, Type 2 | Diabetes

Korea, Republic of
Novo Nordisk A/S

Completed

Observational Study on Safety of Self-titration of Once Daily Levemir® (SOLVE™)

Diabetes Mellitus, Type 2 | Diabetes

United Kingdom
Novo Nordisk A/S

Completed

Observational Study in Type 2 Diabetics Failing on Oral Antidiabetic Therapy and Starting on Insulin Treatment (HA-BOT)

Diabetes Mellitus, Type 2 | Diabetes

Hungary
Novo Nordisk A/S

Completed

Observational Study of Glycaemic Control in Patients Uncontrolled on Oral Antidiabetic Agents and Starting With 1 (Once) Daily Levemir® (Insulin Detemir) as the Treatment of Type 2 Diabetes Mellitus (START)

Diabetes Mellitus, Type 2 | Diabetes

Slovakia
Novo Nordisk A/S

Completed

Observational Study of Safety and Tolerability of Levemir™ FlexPen™ (Insulin Detemir) in the Treatment of Type 1 and Type 2 Diabetes Mellitus

Diabetes Mellitus, Type 2 | Diabetes | Diabetes Mellitus, Type 1

Philippines
Novo Nordisk A/S

Completed

Observational Study to Evaluate the Safety While Using Levemir®

Diabetes Mellitus, Type 2 | Diabetes | Diabetes Mellitus, Type 1

Egypt
Novo Nordisk A/S

Completed

Observational Study to Evaluate the Safety of Levemir® in Diabetes (PREDICTIVE™)

Diabetes Mellitus, Type 2 | Diabetes | Diabetes Mellitus, Type 1

Mexico
Novo Nordisk A/S

Completed

An Observational Study on Efficacy and Safety in Subjects Using Levemir® for the Treatment of Insulin Dependent Type 1 or Type 2 Diabetes

Diabetes Mellitus, Type 2 | Diabetes | Diabetes Mellitus, Type 1

Morocco
Novo Nordisk A/S

Completed

Observational Study of Safety and Efficacy of Levemir® in Type 2 Diabetes (DIABESITY)

Diabetes Mellitus, Type 2 | Diabetes

India
Novo Nordisk A/S

Completed

Observational Study to Observe the Safety of Levemir® Treatment in Patients With Type 2 Diabetes

Diabetes Mellitus, Type 2 | Diabetes

Sweden, Denmark
Vanderbilt University
Novo Nordisk A/S

Active, not recruiting

Insulin Detemir in Obesity Management (IDIOM)

Obesity | Diabetes

United States
Novo Nordisk A/S

Completed

Observational Study to Evaluate the Safety of Levemir® in Type 2 Diabetes (SOLVE™)

Diabetes Mellitus, Type 2 | Diabetes

Israel, Spain, China, Turkey, Germany, Poland, Italy, Canada, Portugal
Novo Nordisk A/S

Completed

Observational Study to Observe the Efficacy of Levemir® (Insulin Detemir) in Patients With Type 2 Diabetes.

Diabetes Mellitus, Type 2 | Diabetes

Switzerland
Novo Nordisk A/S

Completed

Observational Study to Observe the Safety of Levemir® Treatment in Children and Adolescents With Type 1 Diabetes (PREDICTIVE™)

Diabetes Mellitus, Type 2 | Diabetes

Sweden
Novo Nordisk A/S

Completed

Observational Study in Type 2 Diabetes Treated by an Intensive Insulin Treatment (ICT) Containing Once Daily Levemir® (Insulin Detemir) (LEONCET2)

Diabetes Mellitus, Type 2 | Diabetes

Hungary
Novo Nordisk A/S

Completed

Observational Study to Evaluate the Safety and Efficacy of Levemir® in Type 2 Diabetes (IDEALS)

Diabetes Mellitus, Type 2 | Diabetes

Algeria
Novo Nordisk A/S

Completed

An Observational Study in Type 2 Diabetic Patients on Oral Antidiabetic Drugs and Basal Insulin in Near East Countries (BO2NE)

Diabetes Mellitus, Type 2 | Diabetes

Israel, Jordan, Pakistan, Lebanon
Novo Nordisk A/S

Completed

Observational Safety Study in Subjects Using Levemir® (Insulin Detemir) for the Treatment of Type 2 Diabetes Mellitus (LevSafeQD)

Diabetes Mellitus, Type 2 | Diabetes

Saudi Arabia
Nationwide Children's Hospital
Novo Nordisk A/S

Terminated

Use of Levemir® Improves Metabolic and Clinical Status in Cystic Fibrosis-related Diabetes (CFRD)

Cystic Fibrosis Related Diabetes

United States
Novo Nordisk A/S

Completed

Observational Study in Type 2 Diabetics Treated by an Intensive Insulin Treatment of Levemir® (LITHULEV1)

Diabetes Mellitus, Type 2 | Diabetes

Lithuania
Novo Nordisk A/S

Completed

Evaluation of Levemir® for the Treatment of Type 1 and 2 Diabetes (PREDICTIVE™)

Diabetes Mellitus, Type 2 | Diabetes | Diabetes Mellitus, Type 1

Russian Federation
University of Colorado, Denver
Novo Nordisk A/S

Completed

Effectiveness of Adding Subcutaneous Long-Acting Detemir to Insulin Drip Therapy Compared With Standard Insulin Drip Therapy

Diabetes

United States
University of Florida
Novo Nordisk A/S; VA Office of Research and Development

Completed

Effect of a Basal/Pre-Meal Insulin Strategy (Detemir/Aspart) on Insulin Secretion and Action in Type 2 Diabetes

Type 2 Diabetes

United States
University of Texas Southwestern Medical Center
Novo Nordisk A/S

Withdrawn

Aggressive Versus Conservative Blood Glucose Control in Hospitalized Type 2 Diabetic Patients Using Detemir and Aspart Insulin (RASCIN)

Type 2 Diabetes

United States
Indiana University
Novo Nordisk A/S

Completed

Cooperation of Insulin and GLP-1 on Myocardial Glucose Uptake

Type 2 Diabetes

United States
Sydney Children's Hospitals Network
Children's Hospital Colorado; Women's and Children's Hospital, Adelaide; John... and other collaborators

Completed

Cystic Fibrosis - Insulin Deficiency, Early Action (CF-IDEA)

Diabetes | Cystic Fibrosis

Australia, United States
University of Padova

Completed

Endothelial Effects of Basal Insulin: Detemir Versus Glargine

Cardiovascular Disease | Type 2 Diabetes | Endothelial Dysfunction

Italy
The Royal Bournemouth Hospital

Withdrawn

Sub-Cutaneous Insulin in Hyperglycaemic Emergencies

Diabetes Mellitus
University of Washington
National Institute on Aging (NIA)

Completed

Study of Nasal Insulin to Fight Forgetfulness - Long-acting Insulin Detemir - 21 Days (SNIFF-LONG 21)

Mild Cognitive Impairment | Alzheimer's Disease

United States
Wake Forest University Health Sciences
Alzheimer's Association

Completed

Study of Nasal Insulin to Fight Forgetfulness - Long-acting Insulin Detemir - 120 Days (SL120) (SL120)

Mild Cognitive Impairment | Alzheimer's Disease

United States
University of Aarhus

Completed

Effect of NPH Insulin, Insulin Detemir and Insulin Glargine on GH-IGF-IGFBP Axis

Diabetes Mellitus, Type 1

Denmark
Centre Europeen d'Etude du Diabete
Novo Nordisk A/S; Abbott

Completed

Pilot Study of Glycemic Control in Diabetic Hemodialyzed Patients (GlyCEDIA)

Diabetes Mellitus

France
Assistance Publique - Hôpitaux de Paris

Completed

INSUlin Regimens and VASCular Functions (INSUVASC)

Type 2 Diabetes

France
Institut de Recherches Cliniques de Montreal
Novo Nordisk A/S; McMaster University

Completed

Levemir-Body Composition and Energy Metabolism

Type 2 Diabetes

Canada
Novo Nordisk A/S

Terminated

Safety and Efficacy of Inhaled Insulin in Type 1 Diabetes

Diabetes | Diabetes Mellitus, Type 1

United States, Canada
Novo Nordisk A/S
BodyMedia

Completed

Efficacy Evaluation of Different Medication Combination in Type 2 Diabetes Treatment

Diabetes Type 2

United States
Buckinghamshire Healthcare NHS Trust
Novo Nordisk A/S

Unknown

Comparing Long-acting Insulins During Exercise in Type 1 Diabetes

Diabetes Mellitus, Type 1

United Kingdom
Centre Hospitalier Universitaire Dijon

Terminated

Treatment With Continuous Sub-cutaneous Insulin Infusion Via a Portable Pump Versus Discontinuous Insulin Infusion Via Multiple-injections in Type 2 Diabetes (TRICIDIA)

Patient With Type 2 Diabetes Treated With Insulin Using a Baseline/Bolus Strategy

France
Ankara University
Hacettepe University; The Scientific and Technological Research Council of...

Completed

The Effects of Insulin Detemir and Gliclazide-MR Treatments on Endothelial Functions in Patients With Type 2 Diabetes

Type 2 Diabetes Mellitus

Turkey
University of Minnesota

Completed

The Impact of Insulin Therapy on Protein Turnover in Pre-Diabetic Cystic Fibrosis Patients

Cystic Fibrosis

United States
Northumbria University
Newcastle University

Completed

Combined Basal-bolus Insulin and Post-exercise Carbohydrate Feeding Strategy in T1DM

Type 1 Diabetes Mellitus

United Kingdom
Thomas Jefferson University
University of Rochester

Not yet recruiting

Strict Versus Permissive Thresholds for Initiation of Pharmacotherapy in Gestational Diabetes (START 2) (START2)

Pregnancy Related | Gestational Diabetes

United States
University of Surrey
Novo Nordisk A/S

Completed

Detemir Energy Expenditure Study (DEES)

Obesity | Type 2 Diabetes Mellitus

United Kingdom
AstraZeneca
Eli Lilly and Company

Completed

Efficacy of Once-Weekly Exenatide Versus Once or Twice Daily Insulin Detemir in Patients With Type 2 Diabetes

Type 2 Diabetes Mellitus

Ireland, United Kingdom
Thomas Jefferson University
University of Rochester

Not yet recruiting

Strict Versus Permissive Thresholds for Initiation of Pharmacotherapy in Gestational Diabetes (START 1)

Pregnancy Related | Gestational Diabetes

United States
University Hospital Tuebingen
Medical University of Vienna; University of Bern; CenTrial GmbH

Terminated

Weight Gain, Eating Patterns, and Development of Body Composition During Initiation of Basal Insulin Therapy in Patients With Type 2 Diabetes: A Comparison of Insulin Detemir and Insulin Glargine

Obesity | Diabetes

Austria, Germany, Switzerland
University of Texas Southwestern Medical Center
Novo Nordisk A/S

Terminated

Duration of The Honeymoon Phase of Type 1 Diabetes: A Comparison of Insulins Detemir, Glargine and NPH

Type 1 Diabetes

United States

Search clinical trials for: Levemir

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Ghana

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations